Found: 7
Select item for more details and to access through your institution.
Comprehensive Implementation of Shared Decision Making in a Neuromedical Center Using the SHARE TO CARE Program.
- Published in:
- Patient Preference & Adherence, 2023, v. 17, p. 131, doi. 10.2147/PPA.S388432
- By:
- Publication type:
- Article
Is multiple sclerosis progression associated with the HLA-DR15 haplotype?
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2019, v. 5, n. 4, p. 1, doi. 10.1177/2055217319894615
- By:
- Publication type:
- Article
Lipid Mediator Profiles Predict Response to Therapy with an Oral Frankincense Extract in Relapsing-Remitting Multiple Sclerosis.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-65215-6
- By:
- Publication type:
- Article
Boswellic acids reduce Th17 differentiation via blockade of IL-1β-mediated IRAK1 signaling.
- Published in:
- European Journal of Immunology, 2014, v. 44, n. 4, p. 1200, doi. 10.1002/eji.201343629
- By:
- Publication type:
- Article
Clinical associations and characteristics of the polyspecific intrathecal immune response in elderly patients with non-multiple sclerosis chronic autoimmune-inflammatory neurological diseases - a retrospective cross-sectional study.
- Published in:
- Frontiers in Neurology, 2023, p. 1, doi. 10.3389/fneur.2023.1193015
- By:
- Publication type:
- Article
B-cell-depletion reverses dysbiosis of the microbiome in multiple sclerosis patients.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-07336-8
- By:
- Publication type:
- Article
Regression to the Mean and Predictors of MRI Disease Activity in RRMS Placebo Cohorts - Is There a Place for Baseline-to-Treatment Studies in MS?
- Published in:
- PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0116559
- By:
- Publication type:
- Article